The role of αβ- and γδ-T cells in allogeneic donor marrow on engraftment, chimerism, and graft-versus-host disease

被引:28
|
作者
Huang, YM
Cramer, DE
Ray, MB
Chilton, PM
Que, XY
Ildstad, ST
机构
[1] Univ Louisville, Inst Cellular Therapeut, Louisville, KY 40202 USA
[2] Univ Louisville, Dept Pathol, Louisville, KY 40202 USA
关键词
D O I
10.1097/00007890-200112270-00007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. We previously characterized a facilitating cell (FC) in mouse marrow that enables engraftment of allogeneic hematopoietic stem cells (HSCs) without causing graft-versus-host disease (GVHD). The FC shares some cell surface molecules with T cells (Thy1(+), CD3epsilon(+), CD8(+), CD5(+), and CD2(+)) but is T-cell receptor (TCR) negative. Historically, depletion of CD3(+) or CD8(+) cells from rat marrow was associated with an increased rate of failure of engraftment. In this study, we evaluated whether depletion of alphabeta- and gammadelta-TCR+ T cells from donor marrow would retain engraftment potential yet avoid GVHD. Methods. Wistar-Furth rats were conditioned with 950 cGy of total body irradiation and transplanted with ACI bone marrow processed to remove either alphabeta-TCR+, gammadelta-TCR+, or alphabeta- plus gammabeta-TCR+ T cells. Recipients were typed for chimerism at 28 days and monthly thereafter. Results. Recipients of marrow depleted of alphabeta- (group A), gammadelta- (group B), or alphabeta- and gammadelta-TCR+ T cells (group C) engrafted and had an average chimerism level of 73.0 +/- 8.3%, 92.3 +/- 9.2%, and 46.3 +/- 32.8%, respectively. Aggressive T-cell depletion did not remove the FC population (CD8(+)/CD3(+)/TCR-). Group A and group B both developed GVHD, with a higher incidence of GVHD in group B compared to group A. None of the recipients in group C developed GVHD. Conclusions. These data demonstrate that depletion of T cells from rat marrow does not impair engraftment of HSCs, indirectly supporting the existence of FCs in rat marrow. Moreover, donor alphabeta- and gammadelta-TCR+ T cells contribute to GVHD in a nonredundant fashion, although alphabeta-TCR+ T cells are more potent as the effector cells. Finally, the level of donor chimerism is influenced by the composition of the graft, because recipients of marrow that contain alphabeta-TCR+ T cells exhibited significantly higher donor chimerism compared to recipients of marrow depleted of both alphabeta- and gammadelta-TCR+ T cells.
引用
收藏
页码:1907 / 1914
页数:8
相关论文
共 50 条
  • [1] Embryonic stem cells as an alternate marrow donor source: Engraftment without graft-versus-host disease
    Burt, RK
    Verda, L
    Kim, DA
    Oyama, Y
    Luo, KH
    Link, C
    JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (07): : 895 - 904
  • [2] The role of selective depletion of alloreactive donor T cells in graft-versus-host disease after allogeneic bone marrow transplantation.
    Chai, Yihuan
    Qiu, Huiying
    Lv, Hui
    BLOOD, 2006, 108 (11) : 382B - 382B
  • [3] The effect of G-CSF-stimulated donor marrow on engraftment and incidence of graft-versus-host disease in allogeneic bone marrow transplantation
    Ji, SQ
    Chen, HR
    Xun, CQ
    Wang, HX
    Pan, SP
    Xiao, MH
    CLINICAL TRANSPLANTATION, 2001, 15 (05) : 317 - 323
  • [4] RELATION OF BONE-MARROW GRAFT, ENGRAFTMENT, AND GRAFT-VERSUS-HOST DISEASE
    JANSEN, J
    GOSELINK, HM
    VEENHOF, WFJ
    BLOTKAMP, C
    ZWAAN, FE
    EXPERIMENTAL HEMATOLOGY, 1982, 10 : 132 - 132
  • [5] LETHAL GRAFT-VERSUS-HOST DISEASE - MODIFICATION WITH ALLOGENEIC CULTURED DONOR CELLS
    MAUCH, P
    LIPTON, JM
    HAMILTON, B
    OBBAGY, J
    KUDISCH, M
    NATHAN, D
    HELLMAN, S
    BLOOD, 1984, 63 (05) : 1112 - 1119
  • [6] ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC MARROW TRANSPLANTATION
    PARKER, N
    COHEN, T
    NURSING CLINICS OF NORTH AMERICA, 1983, 18 (03) : 569 - 577
  • [7] miR-181a Expression in Donor T Cells Modulates Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation
    Lee, Chun-Wei
    Wohlan, Katharina
    Dallmann, Iris
    Forster, Reinhold
    Ganser, Arnold
    Krueger, Andreas
    Scherr, Michaela
    Eder, Matthias
    Koenecke, Christian
    JOURNAL OF IMMUNOLOGY, 2016, 196 (09): : 3927 - 3934
  • [8] Prevention of graft-versus-host disease by intra-bone marrow injection of donor T cells
    Fukui, Junichi
    Inaba, Muneo
    Ueda, Yusuke
    Miyake, Takashi
    Hosaka, Naoki
    Kwon, A-Hon
    Sakaguchi, Yutaku
    Tsuda, Masanobu
    Omae, Mariko
    Kamiyama, Yasuo
    Ikehara, Susumu
    STEM CELLS, 2007, 25 (06) : 1595 - 1601
  • [9] ENGRAFTMENT OF ALLOGENEIC BONE-MARROW CELLS - EXPERIMENTAL INVESTIGATIONS ON THE ROLE OF CELL DOSE, GRAFT-VERSUS-HOST REACTIVE T-CELLS AND PRETRANSPLANT IMMUNOSUPPRESSION
    UHAREK, L
    GLASS, B
    GASSMANN, W
    ECKSTEIN, V
    STEINMANN, J
    LOEFFLER, H
    MUELLERRUCHHOLTZ, W
    TRANSPLANTATION PROCEEDINGS, 1992, 24 (06) : 3023 - 3025
  • [10] Impaired B Lymphopoiesis Concurrent with Marrow Infiltration By Allogeneic Donor T-Cells: Further Evidence for Bone Marrow Graft-Versus-Host Disease
    Rashidi, Armin
    Bevan, Tandon
    Cashen, Amanda F.
    BLOOD, 2015, 126 (23)